Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Name: Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)
Published: 2017
License: Public Domain

Incyte Corporation · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

head-and-neck-cancer

head and neck cancer, squamous cell carcinoma of the head and neck, programmed cell death protein 1 (pd-1) antibody, indoleamine 2,3-dioxygenase (ido) inhibitor, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310)

Related documents